Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-01-05 @ 8:36 PM
Study NCT ID:
NCT03189433
Status:
TERMINATED
Last Update Posted:
2021-03-30
First Post:
2017-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)
Sponsor:
Eagle Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-14
First Submit QC Date:
None
Study First Post Date:
2017-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-12-04
Results First Submit QC Date:
None
Results First Post Date:
2021-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-29
Last Update Post Date:
2021-03-30
Last Update Post Date Type:
ACTUAL